1285. Systematic Literature Review of Real-world Experience with the 2-Drug Regimen Dolutegravir and Lamivudine in People with HIV Who Would Not Have Met Inclusion Criteria for the Phase 3 Clinical Program

BACKGROUND: In phase 3 randomized controlled trials (RCTs), dolutegravir/lamivudine (DTG/3TC) demonstrated durable efficacy in treatment-naive (GEMINI-1/-2) and virologically suppressed switch (TANGO, SALSA) participants. Eligibility criteria for these RCTs included no history of treatment failure o...

Descripción completa

Detalles Bibliográficos
Autores principales: Slim, Jihad, Ward, Douglas, Schneider, Stefan, Kabra, Madhusudan, Verdier, Gustavo, Jones, Clifford B, Letang, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752516/
http://dx.doi.org/10.1093/ofid/ofac492.1116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752516/
http://dx.doi.org/10.1093/ofid/ofac492.1116

Ejemplares similares